XML 13 R2.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Balance Sheet (Unaudited)
Mar. 31, 2025
USD ($)
Assets:  
Deferred offering costs $ 253,321
Total Assets 253,321
Current liabilities  
Accrued expenses 5,000
Accrued offering costs 24,156
Total Liabilities 276,855
Commitments and Contingencies (Note 6)
Shareholders’ Deficit  
Preference shares, value
Additional paid-in capital 24,241
Accumulated deficit (48,534)
Total Shareholders’ Deficit (23,534)
Total Liabilities and Shareholders’ Deficit 253,321
Class A Ordinary shares  
Shareholders’ Deficit  
Ordinary shares, value
Class B Ordinary shares  
Shareholders’ Deficit  
Ordinary shares, value 759 [1],[2]
Related Party  
Current liabilities  
Promissory note - related party $ 247,699
[1] Includes up to 990,000 Class B ordinary shares that were subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters. On May 2, 2025, the underwriters partially exercised their over-allotment option and forfeited the unexercised balance (see Note 5).
[2] On April 30, 2025, the Company, through a share recapitalization, issued an additional 1,265,000 Class B ordinary shares to the Sponsor, resulting in the Sponsor holding 7,590,000 founder shares, at approximately $0.003 per share. All share and per share data is retroactively presented (see Note 5 and Note 9).